For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
Peer Review Publication of 36- and 48-month Canaloplasty Data Demonstrates Sustained Reduction in IOP with iTrack™
Media Release iTrack
5 May, 2022
2RT Pivotal Study and Regulatory Pathway Presentation
ASX Announcement General AlphaRET
3 May, 2022
Nova Eye Medical Announces Regulatory Pathway for AlphaRET 2RT in the USA
ASX Announcement General AlphaRET
3 May, 2022
Latest Events
See allEuropean Glaucoma Society (EGS) 2022
Athens, Greece
4
- 8 Jun, 2022
Register for updates
Asia Pacific Association of Cataract and Refractive Surgeons (APACRS) 2022
Seoul, South Korea
10
- 12 Jun, 2022
Register for updates
Asia Pacific Glaucoma Congress (APGC) 2022
Kuala Lumpur, Malaysia
5
- 7 Aug, 2022
Register for updates